lonza_logo  
Corporate Home | Contact us | Sitemap |
 
Home > Press Releases > New website on the health benefits of L-Carnitine
 
New website on the health benefits of L-Carnitine
send     print    
Media Releases Financial Reports Presen-tations
29.08.2008 News Release_080829_B2C_Carnipure_Marketing_E_final.pdf    
Basel, Switzerland – Interested consumers can now find information on dietary supplementation with L-Carnitine at www.carnipure-for-you.com. Sixteen short and understandable paragraphs explain what L-Carnitine is, the role it plays in the body and who can benefit from additional intake. An innovative electronic L-Carnitine calculator allows consumers to quickly and easily check how much L-Carnitine they take in on average with a normal diet.


This website, which is available in English and German now, will soon be extended to six other European languages. It is initiated and maintained by Lonza, the leading manufacturer of the raw material L-Carnitine. Lonza offers this product under the brand name Carnipure™ to food-, nutraceutical- and pharmaceutical companies globally. Products which contain Carnipure™ carry the Carnipure™ quality seal on the packaging.

Many foods of animal origin are rich in L-Carnitine, whereas foods of plant origin contain very little, if any. L-Carnitine is essential within the body for the generation of energy from fat, thus it plays an important role in energy metabolism and is important for everybody who leads an active lifestyle and wants to stay healthy.


About Lonza
Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Its products and services span its customers’ needs from research to final product manufacture. Lonza is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Lonza is also a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.

Lonza is headquartered in Basel, Switzerland and is listed on the SWX Swiss Exchange. In 2007, Lonza had sales of CHF 2.87 billion. Further information can be found at www.lonza.com.

For further information:

Lonza Ltd
Scientific Marketing, Nutrition
Ulla Freitas
Tel +41 61 316 8273
ulla.freitas@lonza.com

Lonza Group
Media Relations
Dominik Werner
Tel +41 61 316 8798
dominik.werner@lonza.com